GILLANDERS

Gillanders Arbuthnot & Company Share Price

₹107.63 +3.78 (3.64%)

21 Nov, 2024 14:22

SIP TrendupStart SIP in GILLANDERS

Start SIP

Performance

  • Low
  • ₹104
  • High
  • ₹109
  • 52 Week Low
  • ₹70
  • 52 Week High
  • ₹160
  • Open Price₹104
  • Previous Close₹104
  • Volume46,812

Investment Returns

  • Over 1 Month + 18.93%
  • Over 3 Month + 25.44%
  • Over 6 Month + 28.82%
  • Over 1 Year + 3.74%
SIP Lightning

Smart Investing Starts Here Start SIP with Gillanders Arbuthnot & Company for Steady Growth!

Invest Now

Gillanders Arbuthnot & Company Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • -6.5
  • PEG Ratio
  • 0
  • Market Cap Cr
  • 230
  • P/B Ratio
  • 1.1
  • Average True Range
  • 4.77
  • EPS
  • 0
  • Dividend Yield
  • 0
  • MACD Signal
  • 3.21
  • RSI
  • 66.2
  • MFI
  • 82.63

Gillanders Arbuthnot & Company Financials

Gillanders Arbuthnot & Company Technicals

EMA & SMA

Current Price
₹107.63
+ 3.78 (3.64%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹97.34
  • 50 Day
  • ₹92.77
  • 100 Day
  • ₹90.96
  • 200 Day
  • ₹90.54

Resistance and Support

104.58 Pivot Speed
  • R3 113.07
  • R2 110.48
  • R1 107.17
  • S1 101.27
  • S2 98.68
  • S3 95.37

What's your outlook on Gillanders Arbuthnot & Company?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Gillanders Arbuthnot has an operating revenue of Rs. 381.78 Cr. on a trailing 12-month basis. An annual revenue de-growth of -20% needs improvement, Pre-tax margin of -13% needs improvement, ROE of -22% is poor and needs improvement. The company has a reasonable debt to equity of 8%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 14% and 14% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 7% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 35 which is a POOR score indicating inconsistency in earnings, a RS Rating of 59 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 94 indicates it belongs to a poor industry group of Diversified Operations and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock has poor technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Gillanders Arbuthnot & Company Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-13 Quarterly Results
2024-08-02 Quarterly Results
2024-05-13 Audited Results & Final Dividend
2024-02-12 Quarterly Results
2023-11-10 Quarterly Results

Gillanders Arbuthnot & Company F&O

Gillanders Arbuthnot & Company Shareholding Pattern

69.08%
0%
0%
0.31%
23.43%
7.18%

About Gillanders Arbuthnot & Company

  • NSE Symbol
  • GILLANDERS
  • BSE Symbol
  • 532716
  • Managing Director & CEO
  • Mr. Mahesh Sodhani
  • ISIN
  • INE047B01011

Similar Stocks to Gillanders Arbuthnot & Company

Gillanders Arbuthnot & Company FAQs

Gillanders Arbuthnot & Company share price is ₹107 As on 21 November, 2024 | 14:08

The Market Cap of Gillanders Arbuthnot & Company is ₹229.7 Cr As on 21 November, 2024 | 14:08

The P/E ratio of Gillanders Arbuthnot & Company is -6.5 As on 21 November, 2024 | 14:08

The PB ratio of Gillanders Arbuthnot & Company is 1.1 As on 21 November, 2024 | 14:08

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
 
footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23